Insider buying · SEC Form 4

Insider Buying — Jul 22, 2026

Company insiders — CEOs, CFOs, directors and 10% owners — buying their own company's stock on the open market: every purchase of $250K or more from the previous day's Form 4 filings, largest first, with an AI summary of the day.

1insider buy
$411Kbought in total
1company
0by CEOs, CFOs and other chiefs
CVlargest: $411K

Every qualifying buy, largest first

StockInsiderValueSharesAvg priceTypeFiled
CVCapsoVision, Inc.Eliyahou Harari10% Owner$411K61,068$6.73AddedJul 21, 2026
Form 4 ↗
Bought 61,068 shares at $6.73 avg via Harari Family Trust on July 17; now $7.02 (+4.3% since buy). Post-transaction stake ~3.34M shares. Co-founder adding to large existing position. CapsoVision IPO'd Nasdaq July 2025 at $5.00.

AIThe day in insider buying

SEC Form 4 Insider Scan — July 22, 2026

Scanned the last 24 hours of EDGAR Form 4 filings. 1 qualifying buy (≥ $250K, transaction type P) totalling $411K.

Headline filings

  • CV — Eliyahou Harari (10% Owner) bought 61,068 shares ≈ $411K at $6.73 avg; now $7.02 (+4.3% since buy). (filing)

Notes

Light day for conviction buying. The only qualifying open-market purchase came from CapsoVision Inc. (NASDAQ: CV), a commercial-stage medical technology company focused on capsule endoscopy solutions with an AI-enhanced diagnostic platform. Eliyahou Harari — co-founder and 10%+ owner — added 61,068 shares via the Harari Family Trust at $6.73 on July 17 (filed July 21). The transaction adds to an already substantial stake of ~3.3 million shares. CapsoVision IPO'd on Nasdaq in July 2025 at $5.00; Harari's buy at $6.73 is now modestly in the green at $7.02 (+4.3% since purchase).

The bulk of July 21 Form 4 filings consisted of routine 10b5-1 plan sales (Sea Ltd COO/CCO, CrowdStrike CEO, Phillips 66 EVP, MeiraGTx CFO, AppFolio 10% owner, ZipRecruiter CPO), RSU vesting and mandatory tax-withholding events (AngioDynamics board cluster, Western Digital CLO, BioLife Solutions, Enovix CEO, TWFG executives), and equity compensation grants (Roivant Sciences directors, CrossAmerica Partners directors). A $12.4M purchase by Fairmount Healthcare Fund II LP in Crescent Biopharma (CBIO) was flagged but excluded — it was participation in CBIO's registered public offering, not a discretionary open-market buy. No cluster purchases by operating executives or $1M+ CEO open-market buys were observed in this filing window.

Most-bought stocks, last 30 days

  • AVO $68.8M · 12 buys, 3 insidersMission Produce, Inc.
  • COE $12.1M · 3 buysChina Online Education Group
  • PBLS $10.0M · 1 buyParabilis Medicines, Inc.
  • PSEC $9.35M · 3 buys, 2 insidersProspect Capital Corp
  • NTSK $7.53M · 2 buys, 2 insidersNetskope Inc.
  • HDSN $6.10M · 2 buys, 2 insidersHudson Technologies, Inc.
  • NVCT $4.66M · 8 buys, 2 insidersNuvectis Pharma, Inc.
  • ENR $3.71M · 3 buys, 2 insidersEnergizer Holdings, Inc.
  • GLOO $3.50M · 1 buyGloo Holdings, Inc.
  • WBX $2.25M · 2 buys, 2 insidersWallbox N.V.
  • GGAL $2.09M · 1 buyGrupo Financiero Galicia S.A.
  • NXST $1.99M · 1 buyNexstar Media Group, Inc.
  • ADBE $1.95M · 1 buyAdobe Inc
  • RH $1.83M · 1 buyRH
  • JCTC $1.61M · 2 buys, 2 insidersJewett-Cameron Trading Co. Ltd.
  • FULC $1.48M · 2 buys, 2 insidersFulcrum Therapeutics, Inc.
  • AMS $1.34M · 1 buyAmerican Shared Hospital Services
  • BOLD $1.25M · 3 buys, 2 insidersBoundless Bio, Inc.
  • LILA $1.00M · 1 buyLiberty Latin America Ltd.
  • CRDF $1.00M · 1 buyCardiff Oncology Inc.

All scans

Source: insiders' SEC Form 4 filings — open-market purchases (transaction code P) of $250K or more filed in the previous day. Insiders must file within two business days of a trade, so a purchase can be a day or two older than its filing. Average price = value ÷ shares. Insiders buy for many reasons and a purchase is no guarantee the shares will rise. The summaries are written by AI as a research aid — not financial advice or a recommendation to buy or sell any security, and they can be wrong.

SPX Lens Insider Buying reads the SEC Form 4 filings insiders file after trading their own company's stock and lists every open-market purchase of $250K or more — who bought, their role, how much and at what average price. Insiders sell for many reasons, but they usually buy for one: they think the shares are worth more. It is free, and a new scan is posted every trading day. How to read insider buying →

See where SPX is heading next. The SPX Lens chart shows key levels, live signals and an AI forecast for the next bars — free to try.

Open the live chartOpen in the Stocks tab

© SPX Lens · About · Terms · Privacy — for educational purposes only, not financial advice.